Evidence map›Paper›PMID 31659324›Full record

ArticleNature genetics2019

The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy.

Rik G H Lindeboom, Michiel Vermeulen, Ben Lehner, Fran Supek

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 4 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 4 syntheses or guidelines pooled it, 332 citations in OpenAlex.

  1. Targeting p53 pathways: mechanisms, structures, and advances in therapy.Signal transduction and targeted therapy · 2023
    Pooled it
  2. A stop-gain variant inHGG advances · 2023
    Pooled it
  3. Exploring the relationship betweenFrontiers in neuroscience · 2023
    Pooled it
  4. Pooled it
  5. Article
  6. Impact of differentTranslational lung cancer research · 2026
    Article
  7. Clonal selection of somatic mutations shapes NK cell memory.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Novel HomozygousLife (Basel, Switzerland) · 2026
    Article
  10. CLUAP1 variants cause non-syndromic retinitis pigmentosa.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Nonsense-mediated mRNA decay: friend or foe in cancer biology?Cell communication and signaling : CCS · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Rik G H LindeboomDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-3660-504X
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0003-0836-6894
Ben LehnerSystems Biology Program, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain. ben.lehner@crg.eu.ORCID http://orcid.org/0000-0002-8817-1124
Fran SupekInstitució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. fran.supek@irbbarcelona.org.ORCID http://orcid.org/0000-0002-7811-6711
Institució Catalana de Recerca i Estudis Avançats · ESRadboud University Nijmegen · NL

Funding

European Research Council 616434European Research Council 757700
6 · The paper itself

Abstract

Premature termination codons (PTCs) can result in the production of truncated proteins or the degradation of messenger RNAs by nonsense-mediated mRNA decay (NMD). Which of these outcomes occurs can alter the effect of a mutation, with the engagement of NMD being dependent on a series of rules. Here, by applying these rules genome-wide to obtain a resource called NMDetective, we explore the impact of NMD on genetic disease and approaches to therapy. First, human genetic diseases differ in whether NMD typically aggravates or alleviates the effects of PTCs. Second, failure to trigger NMD is a cause of ineffective gene inactivation by CRISPR-Cas9 gene editing. Finally, NMD is a determinant of the efficacy of cancer immunotherapy, with only frameshifted transcripts that escape NMD predicting a response. These results demonstrate the importance of incorporating the rules of NMD into clinical decision-making. Moreover, they suggest that inhibiting NMD may be effective in enhancing cancer immunotherapy.

Indexed as

Gene EditingImmunotherapyGenetic Diseases, InbornHumansModels, GeneticNeoplasmsNonsense Mediated mRNA DecayRNA, MessengerRNA, Messenger

Identifiers

PMID31659324
PMCPMC6858879
OpenAlexW2981514644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.